News Daily News FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients Yael L. Maxwell May 16, 2019
News Daily News Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease L.A. McKeown May 06, 2019
News Features Peripheral Vision: As Office-Based Practices Proliferate, Who Is Watching Out for Patients? Caitlin E. Cox May 01, 2019
News Daily News Two Pediatric Cardiac Catheters Recalled for Defective Balloons L.A. McKeown April 26, 2019
News Daily News One in Two Americans Have Cardiovascular Disease: AHA Stats Michael O'Riordan February 04, 2019
News Daily News Femoral Operators Get Bad Rap in Observational Studies, HEAT-PPCI Suggests Michael O'Riordan January 21, 2019
News Daily News VTE Risk in Women May Be Higher With Oral vs Transdermal Hormone Replacement Therapies L.A. McKeown January 14, 2019
News Daily News Guidelines for Peripheral Interventions Often Built on Shaky Foundation Caitlin E. Cox January 10, 2019
News Daily News NOACs Significantly Curb Risk of VTE in Cancer Patients L.A. McKeown December 06, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2018 Shelley Wood October 31, 2018
News Daily News More Research Supports Use of Aspirin Alone to Prevent VTE After Knee Replacement Surgery L.A. McKeown October 18, 2018
News Daily News Twenty-Year Data Show No Negative Impact of Radial Artery Harvest on Blood Flow of CABG Patients L.A. McKeown October 08, 2018
News Conference News ESC 2018 My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More Shelley Wood September 14, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2018 Caitlin E. Cox September 04, 2018
News Conference News ESC 2018 Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD Todd Neale August 31, 2018
News Conference News ESC 2018 ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More Shelley Wood August 20, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Daily News European Regulators Nix Portola’s Factor Xa Inhibitor Betrixaban Todd Neale March 23, 2018